1. Market Research
  2. > Healthcare
  3. > Health Services Market Trends

2015 Clinical Chemistry and Immunodiagnostic Testing in US Hospitals, Commercial Laboratories and Point-of-Care/POC Locations

  • June 2015
  • 635 pages
  • Venture Planning Group
Report ID: 2162942

Summary

Table of Contents

Complete report $11,500.  DataPack (test volumes, sales forecasts, supplier shares) $7,500.


“2015 Clinical Chemistry and Immunodiagnostics Testing in US Hospitals, Commercial Laboratories and Point-of-Care/POC Locations” is a new strategic analysis of major business opportunities emerging in the US clinical chemistry and immunodiagnostic hospital, commercial and point-of-care/POC markets during the next five years.  The report explores future trends in the US market; provides estimates of the specimen, test and sales volumes, as well as major suppliers’ sales and market shares; compares features of leading analyzers; profiles key competitors; and identifies specific product and marketing opportunities emerging during the next five years.


The report provides five-year volume and sales forecasts for over 100 clinical chemistry, TDM, endocrine, cancer, immunoprotein and abused drug assays performed in hospitals, commercial laboratories, physician offices,  ER, OR, ICU, cancer clinics, ambulatory care centers, surgery centers, nursing hones, and birth centers, including controls, calibrators and consumables.


Rationale


The clinical chemistry and immunodiagnostic markets are undergoing significant transformation, caused by convergence of new and more stringent regulations; advances in diagnostic technologies, system engineering, automation, and IT; and intensifying competition.  Some segments, like routine chemistry, are already resembling commodity markets, where product positioning and cost per test are more critical than underlying technology.  This evolving marketplace creates exciting opportunities for a variety of new instruments, reagent systems, and auxiliary products, such as specimen preparation devices, controls, and calibrators.


Strategic Recommendations


- New product development opportunities

with significant market appeal.


- Alternative market penetration strategies.


- Potential market entry barriers and risks.


Tests Analyzed in the Report


Routine Clinical Chemistry


Albumin, Alkaline Phosphatase, ALT/SGPT, Ammonia, Amylase, AST/SGOT, Bilirubin, Total,

BUN (Blood Urea Nitrogen), Calcium, Cardio CRP, Carbon Dioxide/Bicarbonate, Chloride,

Cholesterol, Creatine Kinase (CK), CK-MB, Creatinine, CRP, Ferritin, GGT, Glucose,

HDL Cholesterol, Homocysteine, Iron, LDH, LDL Cholesterol, Magnesium, Phosphorus,

Potassium, Protein, Total, Sodium, Triglycerides, Troponin, Uric Acid.


Therapeutic Drug Monitoring (TDM)


Amikacin, Carbamazepine, Cyclosporin, Digoxin, Everolimus, Gentamicin, Levetiracetam,

Lithium, Methotrexate, NAPA/Procainamide, Phenobarbital, Phenytoin, Quinidine, Sirolimus,

Tacrolimus, Theophylline, Tobramycin, Topirimate, Valproic Acid, Vancomycin.


Endocrine Function


Cortisol, Estradiol, FSH, HCG, Gastrin, LH, Progesterone, PTH/IO PTH,

Prolactin, T3, T3 Uptake,  Free T3, T4, Free T4, TBG, Testosterone,

Thyroglobulin Ab,  TPO Ab, TSH.


Tumor Markers and Special Chemistry


AFP, CA 15-3/27-29, CA 19-9, CEA, Ferritin, Follate (Folic Acid),

Glycosylated Hemoglobin, HCG, 25-Hydroxy Vitamin D2 and D3, Occult Blood,

PAP, PSA, Thyroglobulin, Vitamin B-12.


Immunoproteins


C3, C4, Free Light Chains, Haptoglobin, IgA, IgE Specific, IgE Total, IgG, IgM,

Immunofixation, Prealbumin, Protein Electrophoresis.


Drugs of Abuse


Amphetamines, Barbiturates, Benzodiazepines, Cannabinoids/Marijuana, Cocaine,

LSD, Methadone, Methaqualone, Opiates, Phencyclidine (PCP),

Propoxyphene, Tricyclic Antidepressants.


Market Segmentation Analysis


- Comprehensive review of the market

dynamics, trends, structure, size, growth,

and key suppliers.


- Test volume and sales forecasts for over 100 clinical chemistry,

TDM, endocrine, cancer, immunoprotein and abused drug assays,

by market segment:

    

Centralized Testing    

 

- Hospitals

- Commercial/Private Laboratories


POC/Decentralized Testing


- Physician Offices/Group Practices   

- Emergency Rooms       

- Operating/Recovery Suites     

- ICUs/CCUs

- Cancer Clinics       

- Ambulatory Care Centers       

- Surgery Centers

- Nursing Homes

- Birth Centers

   

Current and Emerging Products


- Analysis of current and emerging clinical chemistry

and immunodiagnostic tests.


- Review of current instrumentation technologies, and feature comparison

of high-, medium-, and low-volume/POC analyzers.


Technology Review


- Assessment of current and emerging

technologies, and their potential  market applications.


- Comprehensive lists of companies developing

or marketing new technologies and products by test.


Competitive Strategies


- Strategic assessments of major suppliers and

emerging market entrants, including their sales, product

portfolios, marketing tactics, collaborative

arrangements and new products in R&D. 


- The companies analyzed in the report include:


   - Abbott

   - AdnaGen

   - Agilent Technologies

   - Beckman Coulter/Danaher

   - Biomedical Diagnostics

   - Biomerieux

   - Bio-Rad

   - Diasorin

   - Eiken Chemical

   - Fujirebio

   - Grifols

   - Instrumentation Laboratory

   - Kyowa Medex

   - Matritech/Alere

   - Ortho-Clinical Diagnostics

   - Quest Diagnostics

   - Roche

   - Siemens

   - Sysmex

   - ThermoFisher

   - Tosoh

   - Wako

   - Wallac/PE


Contains 635 pages and 149 tables

“2015 Clinical Chemistry and Immunodiagnostics Testing in US Hospital, Commercial Laboratories and Point-of-Care/POC Locations” is a new strategic analysis of major business opportunities emerging in the US clinical chemistry and immunodiagnostic hospital, commercial and point-of-care/POC markets during the next five years. The report explores future trends in the US market; provides estimates of the specimen, test and sales volumes, as well as major suppliers’ sales and market shares; compares features of leading analyzers; profiles key competitors; and identifies specific product and marketing opportunities emerging during the next five years.

The report provides five-year volume and sales forecasts for over 100 clinical chemistry, TDM, endocrine, cancer, immunoprotein and abused drug assays performed in hospitals, commercial laboratories, physician offices, ER, OR, ICU, cancer clinics, ambulatory care centers, surgery centers, nursing hones, and birth centers, including controls, calibrators and consumables.

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 60 Million searchable statistics with tables, figures & datasets
  • More than 25,000 trusted sources
  • Single User License — provides access to the report by one individual.
  • Department License — allows you to share the report with up to 5 users
  • Site License — allows the report to be shared amongst all employees in a defined country
  • Corporate License — allows for complete access, globally.

Veronica helps you find the right report:

Testimonials

The research specialist advised us on the best content for our needs and provided a great report and follow-up, thanks very much we shall look at ReportLinker in the future.

Kate Merrick

Global Marketing Manager at
Eurotherm by Schneider Electric

We were impressed with the support that ReportLinker’s research specialists’ team provided. The report we purchased was useful and provided exactly what we want.

Category Manager at
Ikea

ReportLinker gave access to reliable and useful data while avoiding dispersing resources and spending too much time on unnecessary research.

Executive Director at
PwC Advisory

The customer service was fast, responsive, and 100% professional in all my dealings (...) If we have more research needs, I'll certainly prioritize working with ReportLinker!

Scott Griffith

Vice President Marketing at
Maurice Sporting Goods

The research specialist provided prompt, helpful instructions for accessing ReportLinker's product. He also followed up to make sure everything went smoothly and to ensure an easy transition to the next stage of my research

Jessica P Huffman

Research Associate at
American Transportation Research Institute

Excellent customer service. Very responsive and fast.

Director, Corporate Strategy at
Ingredion

I reached out to ReportLinker for a detailed market study on the Air Treatment industry. The quality of the report, the research specialist’s willingness to solve my queries exceeded my expectations. I would definitely recommend ReportLinker for in-depth industry information.

Mariana Mendoza

Global Platform Senior Manager at
Whirlpool Corporation

Thanks! I like what you've provided and will certainly come back if I need to do further research works.

Bee Hin Png

CEO at
LDR Pte Ltd

The research specialist advised us on the best content for our needs and provided a great report and follow-up, thanks very much we shall look at ReportLinker in the future.

Kate Merrick

Global Marketing Manager at
Eurotherm by Schneider Electric

Purchase Reports From Reputable Market Research Publishers

2017 Analysis of the Global Tumor Marker Testing Market: Emerging Opportunities and Growth Strategies for Instrument and Reagent Suppliers

  • $ 28500
  • Industry report
  • March 2017
  • by Venture Planning Group

Highlights - Identifies and evaluates major business opportunities emerging in the tumor marker market during the next ten years- Examines trends in the U.S., Europe and Japan- Reviews current and emerging ...

Tumor Markers 2021: Reagents and Instrumentation--Supplier Shares and Strategies, Country Segment Forecasts, Emerging Opportunities

  • $ 21100
  • Industry report
  • March 2017
  • by Venture Planning Group

Complete report $34,750.  DataPack (test volumes, sales forecasts, supplier shares) $21,100. Highlights - Identifies and evaluates major business opportunities emerging in the tumor marker market during ...

2017 Competing in the Global Cancer Diagnostics Market

  • $ 21100
  • Industry report
  • March 2017
  • by Venture Planning Group

This new VPGMarketResearch.com comprehensive seven-country study identifies and evaluates major business opportunities emerging in the cancer diagnostics market during the next five years; examines trends ...


ref:plp2015

Reportlinker.com © Copyright 2017. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.